Similarly, proanthocyanidins used as a therapeutic in an in vitro osteoporosis treatment model inhibited osteoclast formation and function by blocking the JNK signaling pathway in bone marrow macrophages and RAW264.7 cells [56]. Here, MAPK8 is linked to osteoporosis.